A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B-cell lymphomas
Vannata B, Vanazzi A, Negri M, Liptrott SJ, Bartosek AA, Miani M, Di Sanzo A, Cavalli F, Zucca E, Stathis A Hematol Oncol. 2020 Oct 26. doi: 10.1002/hon.2822. Epub ahead of print. PMID: 33103778.
Entrectinib approval by EMA reinforces options for ROS1 and tumour agnostic NTRK targeted cancer therapies
Ardini E, Siena S ESMO Open. 2020 Sep;5(5):e000867. doi: 10.1136/esmoopen-2020-000867. PMID: 32907817; PMCID:PMC7481078.
Increased tumor burden in patients with chronic myeloid leukemia after 36 months of imatinib discontinuation
Diral E, Mori S, Antolini L, Abruzzese E, Le Coutre P, Martino B, Pungolino E, Elena C, Bergamaschi M, Assouline S, Di Bona E, Gozzini A, Andrade-Campos M, Stagno F, Iurlo A, Pirola A, Fontana D, Petiti J, Bonanomi ML, Crivori P, Piazza R, Fava C, Gambacorti-Passerini C Blood. 2020 Nov 5;136(19):2237-2240. doi: 10.1182/blood.2019004371. PMID: […]
61st annual meeting of the Italian Cancer Society
November 6-8 Naples, IT 61st annual meeting of the Italian Cancer Society November 6-8
Technological innovations in medicinal chemistry: the continuous flow processes
June 15, 2018 (1:30 PM) Technological innovations in medicinal chemistry: the continuous flow processes Lucia Tamborini Dipartimento di Scienze Farmaceutiche (DISFARM) University of Milan
ELRIG Forum
March 7 Darmstadt, Germany ELRIG Forum
27th Protein Structure Determination in Industry Meeting
November 3-5 Hinxton, UK 27th Protein Structure Determination in Industry Meeting
17th Discovery on target 2019
September 16-19 Boston, MA 17th Discovery on target 2019
ESMO 2019
September 27-October 01 Barcelona, Spain
XXVI NMMC 2019 Nat ional Meet ing in Medicinal Chemistry
July 16-19 Milano, Cà Granda XXVI NMMC 2019 Nat ional Meet ing in Medicinal Chemistry